Welch & Forbes LLC Danaher Corp Transaction History

Welch & Forbes LLC

$7.64 Billion
Q4 2024

A detailed history of Welch & Forbes LLC transactions in Danaher Corp stock. As of the latest transaction made, Welch & Forbes LLC holds 684,853 shares of DHR stock, worth $139 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares

684,853

Previous 676,150 1.29%

Holding current value

$139 Million

Previous $188 Million 16.36%

% of portfolio

2.06%

Previous 2.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$226.16 - $274.52 $1.97 Million - $2.39 Million	8,703 Added 1.29%	684,853 $157 Million
Q3 2024 Nov 04, 2024	SELL	$239.25 - $280.76 $477,303 - $560,116	-1,995 Reduced 0.29%	676,150 $188 Million
Q2 2024 Aug 01, 2024	BUY	$235.51 - $267.98 $408,374 - $464,677	1,734 Added 0.26%	678,145 $169 Million
Q1 2024 May 02, 2024	BUY	$224.58 - $256.19 $668,799 - $762,933	2,978 Added 0.44%	676,411 $169 Million
Q4 2023 Feb 06, 2024	SELL	$185.1 - $233.13 $537,345 - $676,776	-2,903 Reduced 0.43%	673,433 $156 Million
Q3 2023 Nov 02, 2023	BUY	$233.08 - $265.59 $412,085 - $469,563	1,768 Added 0.26%	676,336 $168 Million
Q2 2023 Jul 28, 2023	BUY	$224.99 - $256.14 $269,313 - $306,599	1,197 Added 0.18%	674,568 $162 Million
Q1 2023 Apr 14, 2023	SELL	$239.75 - $277.0 $463,436 - $535,441	-1,933 Reduced 0.29%	673,371 $170 Million
Q4 2022 Feb 02, 2023	SELL	$241.42 - $282.29 $1.61 Million - $1.88 Million	-6,667 Reduced 0.98%	675,304 $179 Million
Q3 2022 Oct 28, 2022	SELL	$247.06 - $1507.4 $1.5 Million - $9.18 Million	-6,089 Reduced 0.88%	681,971 $176 Million
Q2 2022 Jul 22, 2022	SELL	$237.11 - $299.66 $1.34 Million - $1.69 Million	-5,645 Reduced 0.81%	688,060 $174 Million
Q1 2022 Apr 25, 2022	BUY	$257.27 - $315.76 $924,113 - $1.13 Million	3,592 Added 0.52%	693,705 $203 Million
Q4 2021 Jan 19, 2022	SELL	$292.08 - $329.01 $1.63 Million - $1.84 Million	-5,592 Reduced 0.8%	690,113 $227 Million
Q3 2021 Oct 13, 2021	SELL	$272.21 - $332.43 $2.28 Million - $2.78 Million	-8,376 Reduced 1.19%	695,705 $212 Million
Q2 2021 Jul 22, 2021	BUY	$225.08 - $271.69 $137,748 - $166,274	612 Added 0.09%	704,081 $189 Million
Q1 2021 Apr 14, 2021	SELL	$212.38 - $245.9 $267,174 - $309,342	-1,258 Reduced 0.18%	703,469 $158 Million
Q4 2020 Jan 20, 2021	SELL	$212.5 - $245.46 $413,312 - $477,419	-1,945 Reduced 0.28%	704,727 $157 Million
Q3 2020 Oct 23, 2020	SELL	$177.16 - $215.33 $514,118 - $624,887	-2,902 Reduced 0.41%	706,672 $152 Million
Q2 2020 Jul 15, 2020	SELL	$128.7 - $176.83 $559,716 - $769,033	-4,349 Reduced 0.61%	709,574 $125 Million
Q1 2020 Apr 17, 2020	SELL	$121.39 - $169.05 $287,694 - $400,648	-2,370 Reduced 0.33%	713,923 $98.8 Million
Q4 2019 Jan 17, 2020	BUY	$133.47 - $153.48 $6,273 - $7,213	47 Added 0.01%	716,293 $110 Million
Q3 2019 Oct 11, 2019	SELL	$135.4 - $146.47 $239,387 - $258,958	-1,768 Reduced 0.25%	716,246 $103 Million
Q2 2019 Jul 12, 2019	SELL	$124.88 - $143.73 $1.28 Million - $1.47 Million	-10,260 Reduced 1.41%	718,014 $103 Million
Q1 2019 Apr 29, 2019	SELL	$97.62 - $132.29 $1.23 Million - $1.67 Million	-12,599 Reduced 1.7%	728,274 $96.1 Million
Q4 2018 Feb 05, 2019	SELL	$94.85 - $109.54 $128,332 - $148,207	-1,353 Reduced 0.18%	740,873 $76.4 Million
Q3 2018 Oct 17, 2018	SELL	$98.13 - $108.9 $272,114 - $301,979	-2,773 Reduced 0.37%	742,226 $80.7 Million
Q2 2018 Jul 16, 2018	SELL	$96.1 - $103.24 $559,013 - $600,547	-5,817 Reduced 0.77%	744,999 $73.5 Million
Q1 2018 Apr 12, 2018	BUY	$92.16 - $103.8 $477,480 - $537,787	5,181 Added 0.69%	750,816 $73.5 Million
Q4 2017 Jan 26, 2018	SELL	$85.26 - $94.62 $674,150 - $748,160	-7,907 Reduced 1.05%	745,635 $69.2 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $59.7 Million - $66.7 Million	753,542	753,542 $64.6 Million

Others Institutions Holding DHR

# of Institutions

2,505

Shares Held

549M

Call Options Held

7.03M

Put Options Held

4.69M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $148B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account